Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The pathway of myo-inositol degradation in Aerobacter aerogenes. Conversion of 2-deoxy-5-keto-D-gluconic acid to glycolytic intermediates.

× No keyword cloud information.

16 in total

1. Organization and transcription of the myo-inositol operon, iol, of Bacillus subtilis.

Authors: K I Yoshida; D Aoyama; I Ishio; T Shibayama; Y Fujita
Journal: J Bacteriol Date: 1997-07 Impact factor: 3.490

2. Characterization of myo-inositol utilization by Corynebacterium glutamicum: the stimulon, identification of transporters, and influence on L-lysine formation.

Authors: Eva Krings; Karin Krumbach; Brigitte Bathe; Ralf Kelle; Volker F Wendisch; Hermann Sahm; Lothar Eggeling
Journal: J Bacteriol Date: 2006-09-22 Impact factor: 3.490

3. Identification of two myo-inositol transporter genes of Bacillus subtilis.

Authors: Ken-Ichi Yoshida; Yoshiyuki Yamamoto; Kaoru Omae; Mami Yamamoto; Yasutaro Fujita
Journal: J Bacteriol Date: 2002-02 Impact factor: 3.490

4. Regulation of myo-inositol catabolism in Aerobacter aerogenes.

Authors: T K Sundaram
Journal: J Bacteriol Date: 1972-07 Impact factor: 3.490

5. Synthesis of oxaloacetate in Bacillus subtilis mutants lacking the 2-ketoglutarate dehydrogenase enzymatic complex.

Authors: S H Fisher; B Magasanik
Journal: J Bacteriol Date: 1984-04 Impact factor: 3.490

6. Gas chromatographic analysis of in situ cyclitol utilization by Klebsielleae growing in redwood extracts.

Authors: H W Talbot; R J Seidler
Journal: Appl Environ Microbiol Date: 1979-10 Impact factor: 4.792

7. Characterization of Di-myo-Inositol-1,1(prm1)-Phosphate in the Hyperthermophilic Bacterium Thermotoga maritima.

Authors: V Ramakrishnan; M Verhagen; M Adams
Journal: Appl Environ Microbiol Date: 1997-01 Impact factor: 4.792

8. Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.

Authors: Ken-ichi Yoshida; Masanori Yamaguchi; Tetsuro Morinaga; Maya Ikeuchi; Masaki Kinehara; Hitoshi Ashida
Journal: Appl Environ Microbiol Date: 2006-02 Impact factor: 4.792

9. Characterization of the myo-inositol utilization island of Salmonella enterica serovar Typhimurium.

Authors: Carsten Kröger; Thilo M Fuchs
Journal: J Bacteriol Date: 2008-11-14 Impact factor: 3.490

10. Identification of a gene cluster enabling Lactobacillus casei BL23 to utilize myo-inositol.

Authors: María Jesús Yebra; Manuel Zúñiga; Sophie Beaufils; Gaspar Pérez-Martínez; Josef Deutscher; Vicente Monedero
Journal: Appl Environ Microbiol Date: 2007-04-20 Impact factor: 4.792